During the current funding period, they have made substantial progress in understanding in vitro lymphopoiesis. Perhaps the most important finding for the success of investigations proposed here is that a murine fetal liver cell line, AFT024, can efficiently support differentiation of putative human stem cells at the single cell level into NK cells and myeloid cells while expanding CD34+ progenitors. The role of IL-2, IL-7, c-kit ligand (KL), Flt3 ligand (FL) and IL-3 has been established and they have defined molecular events which occur during this process. This assay will be optimal to address several important questions in NK cell differentiation. There are two related themes as the focus of these investigations. They hypothesize that early differentiation of stem cells into an NK cell restricted progenitor (loss of myeloid capacity) and further NK cell commitment is governed by factor provided by the microenvironment, and factors inherent to the stem cell source. They will use the differentiating of AFT024 to study NK cell differentiation from stem cells using a sequential """"""""switch culture assay"""""""" which allows separation of early and late differentiation stages. The second line of investigation is based on the discovery of class I binding receptors, which are comprised of immunoglobulin-type or lectin-type domains with genes clustered to regions of human chromosomes 19 and 12, respectively. In addition to KIR, other related receptors (LIR-1, LAIR-1) of the immunoglobulin family will also be studied. They hypothesize that inhibitory or activating receptor repertoires are determined late in development and that receptor ligation during development may signal the cell to stop acquiring new receptors.
In Specific Aim 1, the role of cytokines, chemokines, proteoglycans, and the complex microenvironment will be explored in NK cell development using single cell differentiation of stem cell populations from adult marrow and cord blood. The role of these factors in determining the balance between progenitor maintenance and NK cell differentiation will be assessed. These studies integrate well with goals in Specific Aim 2 to study the ontogeny of class I binding receptors and receptors of related families. They will determine how and what developmental stage receptor acquisition occurs in developing NK cells.
In Specific Aim 3, they will evaluate transcription factors within developing cells to determine their role in lineage restriction. Gene manipulation (to over-express or block function) by retroviral transduction into single primitive stem cell populations will verify their role in the differentiation process. Preliminary data suggests a role for targeting TCF-1 as an initial focus using this approach.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL055417-05
Application #
6194801
Study Section
Experimental Immunology Study Section (EI)
Project Start
1996-08-01
Project End
2004-06-30
Budget Start
2000-08-16
Budget End
2001-06-30
Support Year
5
Fiscal Year
2000
Total Cost
$259,875
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Williams, Robin L; Cooley, Sarah; Bachanova, Veronika et al. (2018) Recipient T Cell Exhaustion and Successful Adoptive Transfer of Haploidentical Natural Killer Cells. Biol Blood Marrow Transplant 24:618-622
Ahn, Yong-Oon; Weeres, Matthew A; Neulen, Marie-Luise et al. (2015) Human group3 innate lymphoid cells express DR3 and respond to TL1A with enhanced IL-22 production and IL-2-dependent proliferation. Eur J Immunol 45:2335-42
Weeres, Matthew A; Robien, Kim; Ahn, Yong-Oon et al. (2014) The effects of 1,25-dihydroxyvitamin D3 on in vitro human NK cell development from hematopoietic stem cells. J Immunol 193:3456-62
Ahn, Yong-Oon; Blazar, Bruce R; Miller, Jeffrey S et al. (2013) Lineage relationships of human interleukin-22-producing CD56+ ROR?t+ innate lymphoid cells and conventional natural killer cells. Blood 121:2234-43
Romee, Rizwan; Foley, Bree; Lenvik, Todd et al. (2013) NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17). Blood 121:3599-608
Dezell, Steven A; Ahn, Yong-Oon; Spanholtz, Jan et al. (2012) Natural killer cell differentiation from hematopoietic stem cells: a comparative analysis of heparin- and stromal cell-supported methods. Biol Blood Marrow Transplant 18:536-45
Gleason, Michelle K; Lenvik, Todd R; McCullar, Valarie et al. (2012) Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9. Blood 119:3064-72
Grzywacz, Bartosz; Kataria, Nandini; Kataria, Niketa et al. (2011) Natural killer-cell differentiation by myeloid progenitors. Blood 117:3548-58
Cichocki, Frank; Felices, Martin; McCullar, Valarie et al. (2011) Cutting edge: microRNA-181 promotes human NK cell development by regulating Notch signaling. J Immunol 187:6171-5
Cichocki, Frank; Lenvik, Todd; Sharma, Neeraj et al. (2010) Cutting edge: KIR antisense transcripts are processed into a 28-base PIWI-like RNA in human NK cells. J Immunol 185:2009-12

Showing the most recent 10 out of 25 publications